{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "16870042",
  "DateCompleted": {
    "Year": "2006",
    "Month": "12",
    "Day": "20"
  },
  "DateRevised": {
    "Year": "2008",
    "Month": "12",
    "Day": "12"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "1525-7304",
      "JournalIssue": {
        "Volume": "8",
        "Issue": "1",
        "PubDate": {
          "Year": "2006",
          "Month": "Jul"
        }
      },
      "Title": "Clinical lung cancer",
      "ISOAbbreviation": "Clin Lung Cancer"
    },
    "ArticleTitle": "Lung cancer in women: exploring sex differences in susceptibility, biology, and therapeutic response.",
    "Pagination": {
      "StartPage": "22",
      "EndPage": "29",
      "MedlinePgn": "22-9"
    },
    "Abstract": {
      "AbstractText": [
        "Src tyrosine kinases regulate a large number of important mechanisms in normal and cancerous cells, are overexpressed in a broad range of tumors including lung cancer, and thus represent a potential target for cancer therapy. Preclinical experiments indicate that small-molecule inhibitors of Src block tumor growth, metastasis, and angiogenesis. Phase I data from healthy volunteers also suggest that inhibitors of Src prevent bone resorption. Several phase II trials with small-molecule inhibitors of Src are under way or have been initiated in lung cancer and in other malignancies, as discussed herein."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Cardiothoracic Surgery, Stanford University School of Medicine, CA 94303, USA. jsd@stanford.edu"
          }
        ],
        "LastName": "Donington",
        "ForeName": "Jessica S",
        "Initials": "JS"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Le",
        "ForeName": "Quynh-Thu",
        "Initials": "QT"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Wakelee",
        "ForeName": "Heather A",
        "Initials": "HA"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Clin Lung Cancer",
    "NlmUniqueID": "100893225",
    "ISSNLinking": "1525-7304"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "etiology",
        "metabolism",
        "mortality",
        "therapy"
      ],
      "DescriptorName": "Lung Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk Factors"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Sex Distribution"
    },
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Smoking"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Survival Rate"
    }
  ],
  "NumberOfReferences": "97"
}